Biomarkers in pediatric acute respiratory distress syndrome

Erin F Carlton1, Heidi R Flori1

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.

Insights

Biomarkers offer potential for diagnosing pediatric acute respiratory distress syndrome (PARDS), predicting patient outcomes, and guiding targeted therapies for this severe lung injury. Further research into PARDS biomarkers is crucial for personalized treatment strategies.

Area of Science:

  • Critical Care Medicine
  • Pediatric Pulmonology
  • Biomarker Research

Background:

  • Pediatric acute respiratory distress syndrome (PARDS) is a severe, heterogeneous lung injury lacking single diagnostic indicators.
  • Current PARDS diagnosis relies on combined clinical and physiological variables, with limited predictive capabilities for disease trajectory or treatment response.
  • Understanding PARDS pathophysiology and patient subgroups is essential for effective therapeutic strategies.

Purpose of the Study:

  • To review the role and potential of biomarkers in the diagnosis, prognostication, and therapeutic response assessment of PARDS.
  • To explore how biomarkers can enhance the understanding of PARDS heterogeneity and identify specific patient endotypes.
  • To discuss current and future directions in biomarker research for PARDS.

Main Methods:

  • Literature review of existing studies on biomarkers in pediatric acute respiratory distress syndrome.
  • Analysis of the diagnostic, prognostic, and therapeutic implications of various biomarkers.
  • Discussion of the application of biomarkers in stratifying patients and guiding treatment decisions.

Main Results:

  • Biomarkers show significant promise in improving PARDS diagnosis beyond current clinical criteria.
  • Biomarkers can aid in predicting patient outcomes and identifying individuals at high risk for adverse events.
  • Biomarker research is key to understanding PARDS endotypes and personalizing treatment approaches.

Conclusions:

  • Biomarkers are invaluable tools for advancing the understanding and management of pediatric acute respiratory distress syndrome.
  • Further investigation into PARDS biomarkers is critical for developing targeted therapies and improving patient outcomes.
  • Biomarker discovery and validation are essential for precision medicine in pediatric critical care.

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
473
Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
797
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
397
Assessment of Respiration01:23

Assessment of Respiration

The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
1.8K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
695
Assessment of Airway, Skin Color, and Use of Accessory Muscles01:30

Assessment of Airway, Skin Color, and Use of Accessory Muscles

A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
1.5K